To determine whether LSD1 may be affected in AD and FTD patients, we examined the localization of LSD1 in post-mortem AD, FTD with TDP-43 inclusions (FTD-TDP43), and age-matched control cases. The gene discussed is TARDBP; the disease is Alzheimer disease.